Loading…

NLRP3 inflammasome, a target for therapy in diverse disease states

A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2010-03, Vol.40 (3), p.631-634
Main Authors: Cook, Graham P, Savic, Sinisa, Wittmann, Miriam, McDermott, Michael F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83
cites cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83
container_end_page 634
container_issue 3
container_start_page 631
container_title European journal of immunology
container_volume 40
creator Cook, Graham P
Savic, Sinisa
Wittmann, Miriam
McDermott, Michael F
description A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.
doi_str_mv 10.1002/eji.200940162
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733696969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733696969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</originalsourceid><addsrcrecordid>eNp9kMFPwjAUhxujEUSPXnU3Lw5f27F2RyWoGKJG5dw82SuObAzboeG_twQknsw7_C7f-w4fY6ccuhxAXNGs6AqALAGeij3W5j3B44QnfJ-1AXgSi0xDix15P4OApb3skLUECODAdZvdPI5enmVUzG2JVYW-rugywqhBN6UmsrWLmg9yuFgFJMqLL3KewnrCsL7BhvwxO7BYejrZboeNbwdv_ft49HQ37F-P4kmSZiImaVWSSJVJ0hPU1iqtkSuulUTNhdZEubaQ95RKSaaIlKc9SaBBI_Jcyw672HgXrv5ckm9MVfgJlSXOqV56o6RMs_UFMt6QE1d778iahSsqdCvDwayrmVDN7KoF_mxrXr5XlO_o30wBUBvguyhp9b_NDB6Gf9Xnm0-LtcGpK7wZvwarDFqeaEjlDwdmf6Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733696969</pqid></control><display><type>article</type><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><source>Wiley</source><creator>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</creator><creatorcontrib>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</creatorcontrib><description>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.200940162</identifier><identifier>PMID: 20201018</identifier><language>eng</language><publisher>Weinheim: Wiley-VCH Verlag</publisher><subject>Animals ; Autoimmune Diseases - immunology ; Autoinflammatory ; Cancer ; Carrier Proteins - immunology ; Dermatitis, Contact - immunology ; Diabetes Mellitus, Type 2 - immunology ; Humans ; IL‐1 inhibition ; Immunity, Innate ; Inflammasome ; Inflammation - immunology ; Liver ; Multiprotein Complexes - immunology ; Neoplasms - immunology ; NLR Family, Pyrin Domain-Containing 3 Protein</subject><ispartof>European journal of immunology, 2010-03, Vol.40 (3), p.631-634</ispartof><rights>Copyright © 2010 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</citedby><cites>FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20201018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cook, Graham P</creatorcontrib><creatorcontrib>Savic, Sinisa</creatorcontrib><creatorcontrib>Wittmann, Miriam</creatorcontrib><creatorcontrib>McDermott, Michael F</creatorcontrib><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</description><subject>Animals</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoinflammatory</subject><subject>Cancer</subject><subject>Carrier Proteins - immunology</subject><subject>Dermatitis, Contact - immunology</subject><subject>Diabetes Mellitus, Type 2 - immunology</subject><subject>Humans</subject><subject>IL‐1 inhibition</subject><subject>Immunity, Innate</subject><subject>Inflammasome</subject><subject>Inflammation - immunology</subject><subject>Liver</subject><subject>Multiprotein Complexes - immunology</subject><subject>Neoplasms - immunology</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kMFPwjAUhxujEUSPXnU3Lw5f27F2RyWoGKJG5dw82SuObAzboeG_twQknsw7_C7f-w4fY6ccuhxAXNGs6AqALAGeij3W5j3B44QnfJ-1AXgSi0xDix15P4OApb3skLUECODAdZvdPI5enmVUzG2JVYW-rugywqhBN6UmsrWLmg9yuFgFJMqLL3KewnrCsL7BhvwxO7BYejrZboeNbwdv_ft49HQ37F-P4kmSZiImaVWSSJVJ0hPU1iqtkSuulUTNhdZEubaQ95RKSaaIlKc9SaBBI_Jcyw672HgXrv5ckm9MVfgJlSXOqV56o6RMs_UFMt6QE1d778iahSsqdCvDwayrmVDN7KoF_mxrXr5XlO_o30wBUBvguyhp9b_NDB6Gf9Xnm0-LtcGpK7wZvwarDFqeaEjlDwdmf6Y</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Cook, Graham P</creator><creator>Savic, Sinisa</creator><creator>Wittmann, Miriam</creator><creator>McDermott, Michael F</creator><general>Wiley-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201003</creationdate><title>NLRP3 inflammasome, a target for therapy in diverse disease states</title><author>Cook, Graham P ; Savic, Sinisa ; Wittmann, Miriam ; McDermott, Michael F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoinflammatory</topic><topic>Cancer</topic><topic>Carrier Proteins - immunology</topic><topic>Dermatitis, Contact - immunology</topic><topic>Diabetes Mellitus, Type 2 - immunology</topic><topic>Humans</topic><topic>IL‐1 inhibition</topic><topic>Immunity, Innate</topic><topic>Inflammasome</topic><topic>Inflammation - immunology</topic><topic>Liver</topic><topic>Multiprotein Complexes - immunology</topic><topic>Neoplasms - immunology</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cook, Graham P</creatorcontrib><creatorcontrib>Savic, Sinisa</creatorcontrib><creatorcontrib>Wittmann, Miriam</creatorcontrib><creatorcontrib>McDermott, Michael F</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cook, Graham P</au><au>Savic, Sinisa</au><au>Wittmann, Miriam</au><au>McDermott, Michael F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NLRP3 inflammasome, a target for therapy in diverse disease states</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>40</volume><issue>3</issue><spage>631</spage><epage>634</epage><pages>631-634</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>A role for NLRP3 inflammasome in recurrent and chronic inflammation was initially described in a group of rare autoinflammatory conditions, termed cryopyrin-associated periodic syndrome. Subsequently, inflammasomes have been implicated in the pathology of many common diseases, including cancer, gout and diabetes. Despite diverse pathologies, the central role of the inflammasome in innate defences and tumour elimination suggests common therapeutic approaches to reduce inflammation where appropriate.</abstract><cop>Weinheim</cop><pub>Wiley-VCH Verlag</pub><pmid>20201018</pmid><doi>10.1002/eji.200940162</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2010-03, Vol.40 (3), p.631-634
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_733696969
source Wiley
subjects Animals
Autoimmune Diseases - immunology
Autoinflammatory
Cancer
Carrier Proteins - immunology
Dermatitis, Contact - immunology
Diabetes Mellitus, Type 2 - immunology
Humans
IL‐1 inhibition
Immunity, Innate
Inflammasome
Inflammation - immunology
Liver
Multiprotein Complexes - immunology
Neoplasms - immunology
NLR Family, Pyrin Domain-Containing 3 Protein
title NLRP3 inflammasome, a target for therapy in diverse disease states
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T12%3A02%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NLRP3%20inflammasome,%20a%20target%20for%20therapy%20in%20diverse%20disease%20states&rft.jtitle=European%20journal%20of%20immunology&rft.au=Cook,%20Graham%20P&rft.date=2010-03&rft.volume=40&rft.issue=3&rft.spage=631&rft.epage=634&rft.pages=631-634&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.200940162&rft_dat=%3Cproquest_cross%3E733696969%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4692-e3f7443793e8ca8ff788a171873a81288eed8f0d5776e36aaed653e0808aa1d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733696969&rft_id=info:pmid/20201018&rfr_iscdi=true